RE: Production numbers8 May 2020 23:24
Middle East - what a load of tosh. Laughable you use P/E ratio for valuing this company. Cov 19 is an opportunistic and timely/lucky event for this company to generate decent revenue short term. Attempting to use P/E ratio for this (or any other pharma companies benefiting from Cov 19) shows lack of understanding finance. Also, using 24 hrs, 30 days, 12 months metrics is also ridiculous, as any normal person would know nothing works around the clock for that long. £518m profit? First, get an RNS which says they've sold something, then try and calculate the profit. Where did you get your 60% profit margin from? Can you share the source?
Thing is, these shares are ramped so much it puts some people off.